Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors

NCT04975958 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumor

Interventions

DRUG: AN2025
DRUG: AN0025
DRUG: Atezolizumab 1200 mg in 20 ML Injection

Sponsor

Adlai Nortye Biopharma Co., Ltd.